|Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus|
M Petri, AM Orbai, GS Alarcón, C Gordon, JT Merrill, PR Fortin, IN Bruce, ...
Arthritis & Rheumatism 64 (8), 2677-2686, 2012
|Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis|
LC Coates, A Kavanaugh, PJ Mease, ER Soriano, ...
Arthritis & rheumatology 68 (5), 1060-1071, 2016
|2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis|
JA Singh, G Guyatt, A Ogdie, DD Gladman, C Deal, A Deodhar, ...
Arthritis & Rheumatology 71 (1), 5-32, 2019
|Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised …|
P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ...
The Lancet 389 (10086), 2317-2327, 2017
|International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials|
AM Orbai, M De Wit, P Mease, JA Shea, L Gossec, YY Leung, W Tillett, ...
Annals of the rheumatic diseases 76 (4), 673-680, 2017
|Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis|
SJ Bartlett, AM Orbai, T Duncan, E DeLeon, V Ruffing, K Clegg-Smith, ...
PloS one 10 (9), e0138543, 2015
|Anti-C1q antibodies in systemic lupus erythematosus|
AM Orbai, L Truedsson, G Sturfelt, O Nived, H Fang, GS Alarcón, ...
Lupus 24 (1), 42-49, 2015
|Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016|
AM Orbai, M De Wit, PJ Mease, KC Duffin, M Elmamoun, W Tillett, ...
The Journal of rheumatology 44 (10), 1522-1528, 2017
|Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop|
VP Bykerk, E Lie, SJ Bartlett, R Alten, A Boonen, R Christensen, DE Furst, ...
The Journal of rheumatology 41 (4), 799-809, 2014
|A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature|
NF Chaisson, J Paik, AM Orbai, L Casciola-Rosen, D Fiorentino, S Danoff, ...
Medicine 91 (4), 220, 2012
|Patient reported outcomes in rheumatoid arthritis clinical trials|
AM Orbai, CO Bingham
Current rheumatology reports 17 (4), 28, 2015
|Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis|
AM Orbai, J Weitz, EL Siegel, S Siebert, LJ Savage, SZ Aydin, JJ Luime, ...
The Journal of Rheumatology 41 (11), 2290-2294, 2014
|Feasibility and domain validation of rheumatoid arthritis (RA) flare core domain set: report of the OMERACT 2014 RA Flare Group Plenary|
SJ Bartlett, VP Bykerk, R Cooksey, EH Choy, R Alten, R Christensen, ...
The Journal of rheumatology 42 (11), 2185-2189, 2015
|Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries|
C Gorlier, AM Orbai, D Puyraimond-Zemmour, LC Coates, U Kiltz, ...
Annals of the rheumatic diseases 78 (2), 201-208, 2019
|Patient-reported outcomes in psoriatic arthritis|
AM Orbai, A Ogdie
Rheumatic Disease Clinics 42 (2), 265-283, 2016
|“Stiffness has different meanings, I think, to everyone”: examining stiffness from the perspective of people living with rheumatoid arthritis|
AM Orbai, KC Smith, SJ Bartlett, E De Leon, CO Bingham III
Arthritis care & research 66 (11), 1662-1672, 2014
|Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set|
U Kalyoncu, A Ogdie, W Campbell, CO Bingham, M De Wit, DD Gladman, ...
RMD open 2 (1), e000217, 2016
|Enhanced patient involvement and the need to revise the core set—report from the psoriatic arthritis working group at OMERACT 2014|
W Tillett, L Eder, N Goel, M De Wit, DD Gladman, O FitzGerald, ...
The Journal of rheumatology 42 (11), 2198-2203, 2015
|A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative|
P Højgaard, L Klokker, AM Orbai, K Holmsted, EM Bartels, YY Leung, ...
Seminars in arthritis and rheumatism 47 (5), 654-665, 2018
|Report of the GRAPPA-OMERACT psoriatic arthritis working group from the GRAPPA 2015 annual meeting|
AM Orbai, PJ Mease, M De Wit, U Kalyoncu, W Campbell, W Tillett, L Eder, ...
The Journal of Rheumatology 43 (5), 965-969, 2016